NBY logo

NovaBay Pharmaceuticals (NBY)

Profile

Full Name

NovaBay Pharmaceuticals, Inc.

Ticker Symbol

NBY

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 26, 2007

Indexes

Not included

Website

http://novabay.com

Employees

24

Key Details

Price

$0.53(+8.16%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.78M(-6.45% YoY)

Annual EPS

-$2.53(+98.18% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.53
NBY price is $0.53

30-Day Relative Volume

0.50
NBY 30-day relative volume is 0.50

Price Performance

Price Most recent change

+8.16%
NBY price was up +8.16% on Apr 11, 2025

Price YTD change

-11.67%
NBY price is down -11.67% since January 1st

Price 1-year change

-83.17%
NBY price is down -83.17% year-on-year

Price 3-year change

-99.85%
NBY price is down -99.85% over the past 3 years

Price Range

Price All-time high

$130156.25
NBY price is currently -100.00% below its historical high of $130156.25

Price 3-year low

$0.36
NBY price is currently +47.22% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.08M
NBY market capitalization is $3.08 million

Market cap 3-year change

-78.6%
NBY market capitalization is down -78.6% over the past 3 years

Market cap All-time high

$85.75M
NBY market capitalization is currently -96.41% below its historical high of $85.75 million

Market cap sector rank

8.79%
NBY market capitalization is higher than 8.79% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+464.52%
NBY shares outstanding is up +464.52% year-on-year

Shares Outstanding 3-Year Change

+13748.1%
NBY shares outstanding is up +13748.1% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.40
NBY beta is 0.40

200-day SMA

$0.77
NBY price is currently -31.31% below its 200-day simple moving average

50-day SMA

$0.61
NBY price is currently -13.40% below its 50-day simple moving average

RSI

41.79
NBY 14-day relative strength index is 41.79

Volume

0.50
NBY 30-day relative volume is 0.50

ATR

$0.04
NBY average true range is $0.04

10-day Historical Volatility

78.66%
NBY 10-day historical volatility is 78.66%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$9.78M
NBY annual revenue is $9.78 million

Revenue Analysts estimate

$12.00M
NBY annual revenue is currently -18.49% lower than the consensus analysts' forecast

Revenue 1-year change

-6.45%
NBY annual revenue is down -6.45% year-on-year

Revenue Sector rank

27.1%
NBY annual revenue is higher than 27.1% of companies in Healthcare sector

EPS

EPS

-$2.53
NBY annual earnings per share is -$2.53

EPS Analysts estimate

-$0.86
NBY annual earnings per share is currently +194.19% higher than the consensus analysts' forecast

EPS 1-year change

+98.18%
NBY annual earnings per share is up +98.18% year-on-year

EPS Sector rank

33.86%
NBY annual earnings per share is higher than 33.86% of companies in Healthcare sector

Profit

Gross profit

$6.48M
NBY annual gross profit is $6.48 million

Gross margin

66.26%
NBY annual gross profit margin is 66.26%

Operating profit

-$4.97M
NBY annual operating income is -$4.97 million

Operating margin

-50.85%
NBY annual operating profit margin is -50.85%

Net income

-$7.22M
NBY annual net profit is -$7.22 million

Net margin

-73.85%
NBY annual net profit margin is -73.85%

Expenses

Total expenses

$14.76M
NBY annual total expenses is $14.76 million

Operating expenses

$11.46M
NBY annual total operating expenses is $11.46 million

Cost of goods sold

$3.30M
NBY annual cost of goods sold is $3.30 million

Selling, general & administrative expenses

$11.41M
NBY annual SGA is $11.41 million

Depreciation and amortization

$381.00K
NBY annual depreciation & amortization is $381.00 thousand

Interest expense

$904.00K
NBY annual interest expense is $904.00 thousand

Income tax

-
NBY annual income tax value is unknown

EBIT & EBITDA

EBIT

-$6.31M
NBY annual earnings before interest & taxes is -$6.31 million

EBITDA

-$5.92M
NBY annual EBITDA is -$5.92 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.42M
NBY annual total assets is $3.42 million

Non current assets

$1.49M
NBY annual long term assets is $1.49 million

Current assets

$1.94M
NBY annual total current assets is $1.94 million

Cash and cash equivalents

$430.00K
NBY annual cash & cash equivalents is $430.00 thousand

Accounts receivable

$389.00K
NBY annual accounts receivable is $389.00 thousand

Inventory

$765.00K
NBY annual inventory is $765.00 thousand

Liabilities

Total liabilities

$3.55M
NBY annual total liabilities is $3.55 million

Long term liabilities

$709.00K
NBY annual total long term liabilities is $709.00 thousand

Current liabilities

$2.84M
NBY annual total current liabilities is $2.84 million

Accounts payable

$623.00K
NBY annual accounts payable is $623.00 thousand

Debt

Total debt

$1.67M
NBY annual total debt is $1.67 million

Total debt 1-year change

-36.01%
NBY annual total debt is down -36.01% year-on-year

Long term debt

$709.00K
NBY annual long term debt is $709.00 thousand

Short term debt

$963.00K
NBY annual short term debt is $963.00 thousand

Equity & Capital

Shareholders equity

-$129.00K
NBY annual stockholders equity is -$129.00 thousand

Book value

-$135.00K
NBY annual book value is -$135.00 thousand

Retained earnings

-$183.46M
NBY annual retained earnings is -$183.46 million

Working capital

-$908.00K
NBY annual working capital is -$908.00 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$5.18M
NBY annual cash flow from operations is -$5.18 million

Cash from operations 1-year change

-21.64%
NBY annual cash flow from operations is down -21.64% year-on-year

Cash from investing

$1.06M
NBY annual cash flow from investing activities is $1.06 million

Cash from investing 1-year change

+5700%
NBY annual cash flow from investing activities is up +5700% year-on-year

Cash from financing

$1.50M
NBY annual cash flow from financing activities is $1.50 million

Cash from financing 1-year change

-21.47%
NBY annual cash flow from financing activities is down -21.47% year-on-year

CAPEX

CAPEX

$6000.00
NBY annual capital expenditures is $6000.00

CAPEX 1-year change

-68.42%
NBY annual capital expenditures is down -68.42% year-on-year

Free Cash Flow

Free cash flow

-$5.19M
NBY annual free cash flow is -$5.19 million

Free cash flow 1-year change

-21.24%
NBY annual free cash flow is down -21.24% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

66.26%
NBY annual gross profit margin is 66.26%

Operating margin

-50.85%
NBY annual operating profit margin is -50.85%

Net margin

-73.85%
NBY annual net profit margin is -73.85%

ROA & ROE

ROA

-115.97%
NBY annual return on assets is -115.97%

ROE

-453.56%
NBY annual return on equity is -453.56%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NBY price to earnings ratio value is unknown

PE ratio Sector rank

-
NBY price to earnings ratio is unknown

PB Ratio

PB ratio

-22.83
NBY price to book ratio is -22.83

PB ratio Sector rank

1.64%
NBY price to book ratio is higher than 1.64% of companies in Healthcare sector

PS Ratio

PS ratio

0.32
NBY price to sales ratio is 0.32

PS ratio Sector rank

10.9%
NBY price to sales ratio is higher than 10.9% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.32M
NBY enterprise value is $4.32 million

Enterprise value Sector rank

19.21%
NBY enterprise value is higher than 19.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.73
NBY EV/EBITDA is -0.73

EV/EBITDA Sector rank

47.22%
NBY EV/EBITDA is higher than 47.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.68
NBY annual current ratio is 0.68

Quick ratio

0.41
NBY annual quick ratio is 0.41

Leverage

Debt to equity

-4.38
NBY annual debt to equity ratio is -4.38

Interest coverage ratio

-6.98
NBY annual interest coverage ratio is -6.98

Risk & Stability

Piotroski F-Score

4
NBY piotroski f-score is 4

Altman Z-Score

-78.05
NBY altman z-score is -78.05

Analyst ratings

Recent major analysts updates

Nov 11, 24 Ascendiant Capital
Buy
Aug 11, 23 Ladenburg Thalmann
Buy
May 20, 22 Ascendiant Capital
Buy
Sep 18, 19 Ladenburg Thalmann
Buy
Mar 13, 19 H.C. Wainwright
Neutral
Mar 26, 18 Roth Capital
Neutral
Jun 5, 17 Roth Capital
Buy
Mar 7, 16 Maxim Group
Hold
Apr 30, 15 Maxim Group
Buy
Mar 6, 13 Ascendiant Capital
Strong Buy

Institutional Ownership

Similar stocks

RDHL logo
RedHill Biopharma (RDHL)
SPRC logo
SciSparc (SPRC)
SNPX logo
Synaptogenix (SNPX)
GLTO logo
Galecto (GLTO)
TTOO logo
T2 Biosystems (TTOO)
QNRX logo
Quoin Pharmaceuticals (QNRX)
TOVX logo
Theriva Biologics (TOVX)
GLMD logo
Galmed Pharmaceuticals (GLMD)
TLIS logo
Talis Biomedical (TLIS)
  • What is the ticker symbol for NovaBay Pharmaceuticals?
  • Does NovaBay Pharmaceuticals pay dividends?
  • What sector is NovaBay Pharmaceuticals in?
  • What industry is NovaBay Pharmaceuticals in?
  • What country is NovaBay Pharmaceuticals based in?
  • When did NovaBay Pharmaceuticals go public?
  • Is NovaBay Pharmaceuticals in the S&P 500?
  • Is NovaBay Pharmaceuticals in the NASDAQ 100?
  • Is NovaBay Pharmaceuticals in the Dow Jones?
  • When was NovaBay Pharmaceuticals's last earnings report?
  • When does NovaBay Pharmaceuticals report earnings?
  • Should I buy NovaBay Pharmaceuticals stock now?

What is the ticker symbol for NovaBay Pharmaceuticals?

The ticker symbol for NovaBay Pharmaceuticals is NYSE American:NBY

Does NovaBay Pharmaceuticals pay dividends?

No, NovaBay Pharmaceuticals does not pay dividends

What sector is NovaBay Pharmaceuticals in?

NovaBay Pharmaceuticals is in the Healthcare sector

What industry is NovaBay Pharmaceuticals in?

NovaBay Pharmaceuticals is in the Biotechnology industry

What country is NovaBay Pharmaceuticals based in?

NovaBay Pharmaceuticals is headquartered in United States

When did NovaBay Pharmaceuticals go public?

NovaBay Pharmaceuticals's initial public offering (IPO) was on October 26, 2007

Is NovaBay Pharmaceuticals in the S&P 500?

No, NovaBay Pharmaceuticals is not included in the S&P 500 index

Is NovaBay Pharmaceuticals in the NASDAQ 100?

No, NovaBay Pharmaceuticals is not included in the NASDAQ 100 index

Is NovaBay Pharmaceuticals in the Dow Jones?

No, NovaBay Pharmaceuticals is not included in the Dow Jones index

When was NovaBay Pharmaceuticals's last earnings report?

NovaBay Pharmaceuticals's most recent earnings report was on Aug 12, 2021

When does NovaBay Pharmaceuticals report earnings?

The date for NovaBay Pharmaceuticals's next earnings report has not been announced yet

Should I buy NovaBay Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page